Omega-3 Fatty Acids and Skeletal Muscle Health
Open accessThe DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index; 68 of the 207 sources its claims cite were checked for support.
Abstract
Skeletal muscle is a plastic tissue capable of adapting and mal-adapting to physical activity and diet. The response of skeletal muscle to adaptive stimuli, such as exercise, can be modified by the prior nutritional status of the muscle. The influence of nutrition on skeletal muscle has the potential to substantially impact physical function and whole body metabolism. Animal and cell based models show that omega-3 fatty acids, in particular those of marine origin, can influence skeletal muscle metabolism. Furthermore, recent human studies demonstrate that omega-3 fatty acids of marine origin can influence the exercise and nutritional response of skeletal muscle. These studies show that the prior omega-3 status influences not only the metabolic response of muscle to nutrition, but also the functional response to a period of exercise training. Omega-3 fatty acids of marine origin therefore have the potential to alter the trajectory of a number of human diseases including the physical decline associated with aging. We explore the potential molecular mechanisms by which omega-3 fatty acids may act in skeletal muscle, considering the n-3/n-6 ratio, inflammation and lipidomic remodelling as possible mechanisms of action. Finally, we suggest some avenues for further research to clarify how omega-3 fatty acids may be exerting their biological action in skeletal muscle.
Overview
CoChat Summary
TL;DR
This narrative review argues that marine omega-3 PUFAs (EPA/DHA) can influence skeletal muscle metabolism, anabolism, insulin sensitivity, inflammation, and lipidome remodelling, with human evidence strongest for enhanced muscle protein synthesis and some functional benefits. It concludes that human trial results remain mixed, likely due to high n-6/n-3 ratios, individual variation, and unresolved dose/placebo issues.
Key findings
- Human RCTs: 8-week supplementation with 1.86 g EPA + 1.5 g DHA/day augmented the muscle protein synthesis response to a hyperinsulinemic-hyperaminoacidemic clamp in older adults without affecting basal MPS, with a similar trend in young/middle-aged individuals; 6 months of 1.8 g EPA + 1.5 g DHA/day ameliorated age-related declines in lean muscle mass and increased hand grip and 1-RM strength. A 90-day trial of 2 g/day omega-3 plus progressive resistance exercise improved strength and neuromuscular function, but omega-3 alone had no effect.
- In C2C12 myotubes, EPA increased MPS 25% greater than control, while DHA had no effect despite elevated p70S6K1 phosphorylation in both treatments; EPA may reduce protein degradation via NF-κB/MURF-1 signalling, and one study found DHA attenuated degradation more efficiently than EPA.
- Metabolic/insulin findings: 3 weeks of omega-3 supplementation increased fat oxidation by 35% at the expense of glucose utilization after a glucose bolus, but human glucose homeostasis trials are equivocal, with some showing no effect or adverse effects. Proposed protective mechanisms include increased incorporation of fatty acids into complex lipids, reduced inflammatory signalling, and PPARγ/NF-κB effects.
- Inflammation/lipidome: EPA-derived eicosanoids are up to 50%–80% less biologically active than arachidonic acid-derived eicosanoids; the threshold for EPA to reduce prostaglandin E2 was between 1.35 and 2.75 g/day, and muscle total lipid/phospholipid omega-3 enrichment increased approximately two-fold over 4–12 weeks of supplementation.
Methods
- Narrative review synthesizing animal, cell-based, and human studies on omega-3 PUFAs and skeletal muscle health, including two summary tables of studies.
- No systematic search strategy, inclusion criteria, risk-of-bias assessment, or meta-analysis is described (evident from the text).
- Main analysis is a qualitative synthesis of proposed mechanisms: muscle anabolism, metabolic flexibility/insulin resistance, inflammation, and lipidome remodelling.
Limitations
- Stated: human trial results are equivocal; no consensus exists on an effective omega-3 dose, there is no apparent dose-response relationship, and individual variation in tissue uptake/lipidomic response may mask effects.
- Stated: placebo choice is key; high omega-6 corn oil controls may have metabolic effects and may not represent a true placebo, and the authors hypothesize that a high n-6/n-3 ratio limits omega-3 effects.
- Evident: as a narrative review, it does not systematically appraise study quality, and many mechanistic conclusions derive from cell or rodent models and remain to be confirmed in human skeletal muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
47 Valid · 7 Not valid · 82 Not checked · 54 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“there are a number of human, animal and cell studies which support a potential role of omega-3 PUFAs in the treatment of IR/T2D through alterations in muscle metabolism”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 5. Skeletal Muscle Metabolic Flexibility and Insulin Resistance
What the sources say
- Not checked yetcites [100] Lanza I.R. Blachnio-Zabielska A. Zabielski P. Nair K.S. Jensen M. Lebrasseur N. Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet Am. J. Physiol. Endocrinol. Metab. 2013 304 E1391 E1403 10.1152/ajpendo.00584.2012 23632634 PMC4116354 source
- Partly supportedcites [123] Wu J.H.Y. Micha R. Imamura F. Pan A. Biggs M.L. Ajaz O. Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: A systematic review and meta-analysis Br. J. Nutr. 2012 107 S214 S227 10.1017/S0007114512001602 22591895 PMC3744862 sourceExperimental — accuracy not yet measured
The Introduction reports that animal studies suggest omega-3 PUFAs can improve insulin sensitivity, and the Discussion (ALA and DM risk; page unavailable) describes some human trials with improved markers of insulin resistance. The paper does not establish a treatment role through alterations in muscle metabolism or identify muscle metabolism as the mechanism; it describes hepatic and inflammatory pathways instead and notes mixed human findings. (LLM, conf=0.85)
- Disputedcites [124] Akinkuolie A.O. Ngwa J.S. Meigs J.B. Djoussé L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials Clin. Nutr. 2011 30 702 707 10.1016/j.clnu.2011.08.013 21959352 PMC5066815 sourceExperimental — accuracy not yet measured
The Conclusion (page unavailable) says the meta-analysis is consistent with a lack of omega-3 PUFA effects on insulin sensitivity, rather than evidence for treating insulin resistance. The Discussion (page unavailable) likewise reports no overall association. The cited paper does not establish the proposed muscle-metabolism mechanism or summarize supporting animal and cell studies. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [125] Hartweg J. Perera R. Montori V. Dinneen S. Neil H.A.W. Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus Cochrane Database Syst. Rev. 2008 CD003205 10.1002/14651858.CD003205.pub2 18254017 PMC9006221 sourceExperimental — accuracy not yet measured
The Background (Main results; page not provided) reviews human trials of omega-3 supplementation in type 2 diabetes, supporting that limited part of the claim. It reports no significant effect on glycemic control or fasting insulin, however, and does not establish a treatment effect through muscle metabolism or report supporting animal and cell studies. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Loss of muscle mass with progressing age is an inevitable aspect of the aging process [5].”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 1. Introduction
What the sources say
- Partly supportedcites [5] Rosenberg I.H. Sarcopenia: Origins and clinical relevance J. Nutr. 1997 127 990S 991S 10.1016/j.cger.2011.03.003 9164280 sourceExperimental — accuracy not yet measured
The discussion of age-related decline (p. 990S) describes loss of lean body mass as a striking feature of aging. But the paper asks whether such decline is a necessary part of aging or can be influenced, and suggests strength training might alter it. It therefore does not establish that muscle loss is inevitable. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“While ALA is the preferred substrate for ∆6 desaturase, an abundance of dietary linoleic acid has been shown to suppress conversion of ALA to DHA [33], which may be a confounding factor in these studies.”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
What the sources say
- Supportedcites [33] Smink W. Gerrits W.J.J. Gloaguen M. Ruiter A. van Baal J. Linoleic and α-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs Animal 2012 6 262 270 10.1017/S1751731111001479 22436184 source
The Abstract and Discussion of Smink et al. (2012) report that high LA intake decreased hepatic EPA (~35%) and DHA (~20%) (all P < 0.001), and the Brain/conclusion passage states explicitly that 'high dietary LA intake inhibits the conversion of ALA into n-3 LC-PUFA'. The Discussion also states that D6 desaturase 'has been reported to have a higher affinity for ALA than for LA', covering the first clause of the citing sentence. The effect was demonstrated in liver (and plasma) of growing gilts; the same passages note brain DHA was virtually unaffected by dietary LA and ALA, a limitation of scope rather than a contradiction of the attributed point. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent evidence suggests that manipulating the omega-3 polyunsaturated fatty acid (PUFA) content of skeletal muscle may improve muscle function and metabolism [10,11].”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 1. Introduction
What the sources say
- Partly supportedcites [10] Smith G.I. Julliand S. Reeds D.N. Sinacore D.R. Klein S. Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults Am. J. Clin. Nutr. 2015 102 115 122 10.3945/ajcn.114.105833 25994567 PMC4480667 sourceExperimental — accuracy not yet measured
Smith et al. (2015) support the muscle-function half of the claim: their 6-mo RCT in healthy older adults found increased thigh muscle volume, handgrip strength and 1-RM strength with fish oil-derived n-3 PUFA therapy (Results, 'Effects of n-3 PUFA therapy on body weight, body fat, and muscle mass and function'; Abstract conclusion). The 'metabolism' half is not this trial's own finding — the Discussion mechanism paragraph credits mitochondrial biogenesis/content, reduced intramyocellular triglyceride and increased muscle protein synthesis to cell-culture and animal studies (refs 40, 43-45) and to their earlier 2011 paper (ref 39), and the trial's own metabolic measures (body fat, intermuscular fat, plasma lipids, glucose/OGTT) were all unchanged (Table 2). Also, the intervention was assessed by red blood cell n-3 PUFA content (+135%), not by measured skeletal-muscle PUFA content, so 'manipulating the omega-3 PUFA content of skeletal muscle' is stated at a level this source does not directly demonstrate. (LLM, conf=0.75)
- Not checked yetcites [11] Rodacki C.L.N. Rodacki A.L.F. Pereira G. Naliwaiko K. Coelho I. Pequito D. Fernandes L.C. Fish-oil supplementation enhances the effects of strength training in elderly women Am. J. Clin. Nutr. 2012 95 428 436 10.3945/ajcn.111.021915 22218156 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Yet, when end point measures such as cardiovascular disease are taken together in a meta-analysis the results of omega-3 supplementation are equivocal [40,41,42,43].”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
What the sources say
- Supportedcites [40] Hooper L. Thompson R.L. Harrison R.A. Summerbell C.D. Ness A.R. Moore H.J. Davey Smith G. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: Systematic review BMJ 2006 332 752 760 10.1136/bmj.38755.366331.2F 16565093 PMC1420708 source
The Abstract (p. 1) states that across 48 RCTs 'the trial results were inconsistent' with no strong evidence of reduced risk of combined cardiovascular events (RR 0.95, 0.82 to 1.12), and the 'Combined cardiovascular events' section reports 'no definite effect ... but confidence intervals were wide ... and inconsistency was high (I2 = 65%)'. The Interpretation section makes the equivocity explicit: 'It is not clear whether long chain or short chain omega 3 fats (together or separately) reduce or increase total mortality, cardiovascular events, cancer, or strokes.' The supplementation component is covered too, since subgrouping 'by advice to eat oily fish versus supplements did not generate robust effects of omega 3 fats on cardiovascular events.' (LLM, conf=0.90)
- Not checked yetcites [41] Rizos E.C. Ntzani E.E. Bika E. Kostapanos M.S. Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis JAMA 2012 308 1024 1033 10.1001/2012.jama.11374 22968891 source
- Partly supportedcites [42] Djoussé L. Akinkuolie A.O. Wu J.H.Y. Ding E.L. Gaziano J.M. Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis Clin. Nutr. 2012 31 846 853 10.1016/j.clnu.2012.05.010 22682084 PMC3509256 sourceExperimental — accuracy not yet measured
Our copy does carry the general point that omega-3 effects on cardiovascular outcomes have been inconsistent: the background section states that although 'marine omega-3 fatty acids may reduce the risk of CHD deaths', 'their association with non-fatal CHD or blood pressure has been inconsistent' and that HF findings 'have not been consistent across studies'. However, this paper is a meta-analysis of observational prospective cohorts of fish intake and biomarker EPA/DHA on incident heart failure (Abstract > Results: 7 studies, 176,441 subjects, pooled RR 0.85 for fish and 0.86 for omega-3), not of omega-3 supplementation trials, and its own pooled conclusion is 'consistent with a lower risk of heart failure' rather than equivocal; the Discussion also concedes the inference is observational and 'cannot exclude chance, residual or unmeasured confounding'. The supplementation element and the 'equivocal overall CVD endpoint' framing are therefore not this source's finding — the inconsistency it describes is credited to other works it cites (e.g. Hooper et al., BMJ 2006; Geleijnse et al., J Hypertens 2002). (LLM, conf=0.70)
- Partly supportedcites [43] Marik P.E. Varon J. Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review Clin. Cardiol. 2009 32 365 372 10.1002/clc.20604 19609891 PMC6653319 sourceExperimental — accuracy not yet measured
The Introduction (p. 365-366) does state that 'the results of prospective interventional studies and meta-analyses have produced mixed results,' which partly matches the claim's 'equivocal' framing, but that remark is about earlier meta-analyses (their refs 8-11), not about Marik and Varon's own pooled result. Their own meta-analysis of 11 trials (39 044 patients; Discussion) concludes that supplementation for a year or longer 'significantly reduces the risk of cardiovascular deaths, sudden cardiac death, all-cause mortality, and nonfatal cardiovascular events' (e.g. CV-death OR 0.87 [0.76, 0.99], p = 0.04; overall nonfatal/CV-event ORs 0.92 [0.85, 0.99] and 0.87 [0.79, 0.95]), i.e. a definite benefit rather than an equivocal one. So the part of the claim that this source's own end-point meta-analysis is equivocal is not supported. (LLM, conf=0.70)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
96 more claims · 33 with their cited sources checked
Create a free account to see all 190 claims and to verify the 139 references still open.
- It may state two separate claims as one. 78
- Probably not a substantial claim. 23
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Omega-3 PUFAs may influence skeletal muscle health and function [89]”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [89]
In the citing paper
“The omega-3 PUFAs (DHA and EPA) are known for their anti-inflammatory properties [32], and marine-derived omega-3 PUFAs can influence the exercise and nutritional response of skeletal muscle [33].”
From Novel Insights on Intake of Fish and Prevention of Sarcopenia: All Reasons for an Adequate Consumption (2020) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 4. Skeletal Muscle Anabolism
“| Smith et al. (2011) [63] | Human | 8 weeks, 1.86 g EPA, 1.5 g DHA daily | Augmented MPS and enahnced mTOR and p70S6K1 signalling in response to a hyperaminoacidemic-hyperinsulinemic clamp in young volunteer. |”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > References
“63. Smith G.I. Atherton P. Reeds D.N. Mohammed B.S. Rankin D. Rennie M.J. Mittendorfer B. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: A randomized controlled trial”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 3. EPA vs. DHA
“docosapentaenoic acid (DHA, 22:6)”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
“docosahexaenoic acid (DHA 22:6n-3)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
“this n-3/n-6 ratio began to diverge and now in the typical western diet is thought to be as much as 20:1”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 3. EPA vs. DHA
“The typical western diet, however, is deficient in omega-3 PUFAs and abundant in omega-6 fatty acids [54].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
“alpha-linoleic acid (ALA 18:3n-3)”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
“supplementing with stearidonic acid (18:3n-3) may improve the efficiency of conversion to DHA”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 2. Dietary Fatty Acid Sources and the Influence of the n-3/n-6 Ratio on Metabolic Health
“LA is converted to arachidonic acid (AA 22:4n-6).”
§ Omega-3 Fatty Acids and Skeletal Muscle Health > 6. Inflammation
“arachidonic acid (AA, 20:4)”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417 · cited 1×
“and are formed in order to allow the compartmentalisation of the membrane for the coordination of function by providing scaffolding to stabilise protein-protein and lipid-lipid interactions involved in signal transduction and trafficking [172].”
BackgroundEvidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 2×
“Animal models that lack MURF-1 expression are protected from atrophy [71,72].”
BackgroundOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 1×
“genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
BackgroundEsposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“general are associated with IR and in C18:2-CoA accumulation is a potential indicator of IR [115,117].”
BackgroundThe healthcare costs of sarcopenia in the United States
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52014.x · Cited by 1,546
The underappreciated role of muscle in health and disease
Wolfe, R. R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.3.475 · Cited by 1,537
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2640fje · Cited by 1,211 · cited 1×
“wasting conditions, such as sarcopenia, is an impaired MPS response to anabolic stimuli [80].”
BackgroundInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1×
“This n-6/n-3 ratio is linked to an increased state of chronic inflammation, which has been linked to diseases such as T2D and obesity [55].”
BackgroundSimopoulos, A. P. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.080 · Cited by 1,143
Mixed muscle protein synthesis and breakdown after resistance exercise in humans
Phillips, S. M., Tipton, K. D., Aarsland, A., Wolf, S. E., & Wolfe, R. R. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e99 · Cited by 1,132 · cited 1×
“will lead to a positive balance and ultimately hypertrophy [56].”
BackgroundVessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 16×
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
BackgroundInfluentialOmega-3 Fatty Acids and Inflammatory Processes
Calder, P. C. (2010) · Nutrients · doi:10.3390/nu2030355 · Cited by 1,116
Membrane fluidity and its roles in the perception of environmental signals
Los, D. A., & Murata, N. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.08.002 · Cited by 1,020 · cited 1×
“Alternatively, fatty acids are incorporated into cellular membranes; the length of the carbon chain, number and position of double bonds of the fatty acids composing the membrane determine the physico-chemical properties such as fluidity [27].”
BackgroundRizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Blasbalg, T. L., Hibbeln, J. R., Ramsden, C. E., Majchrzak, S. F., & Rawlings, R. R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006643 · Cited by 881 · cited 1×
“The typical western diet, however, is deficient in omega-3 PUFAs and abundant in omega-6 fatty acids [54].”
BackgroundDocosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872 · cited 2×
“membrane fluidity can alter the activity of membrane associated proteins, membrane receptors and vesicle budding and fusion [29,30].”
BackgroundBorkman, M., Storlien, L. H., Pan, D. A., Jenkins, A. B., Chisholm, D. J., & Campbell, L. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280404 · Cited by 835 · cited 1×
“As such, insulin resistance is associated with decreasing concentration of PUFAs in serum and muscle phospholipids [170].”
BackgroundShakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Burdge, G. C., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002689 · Cited by 812 · cited 1×
“However, the conversion of ALA to DHA is very inefficient with <10% conversion in females and <3% in males [31,32].”
BackgroundThe composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807 · cited 2×
“The potential therapeutic benefit of a diet with high omega-3 content was first observed due to the lower incidence of CVD in Greenland Inuit populations [17].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.003 · Cited by 786
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1×
“(2005) was an increase in mRNA content of GLUT1, which is involved in the regulation of basal glucose uptake [132,139].”
BackgroundTotal-body skeletal muscle mass: Estimation by a new dual-energy X-ray absorptiometry method
Kim, J., Wang, Z., Heymsfield, S. B., Baumgartner, R. N., & Gallagher, D. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.378 · Cited by 737
Baar, K., & Esser, K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.1.c120 · Cited by 726
Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676 · cited 1×
“are equivocal [40–43].”
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 15×
“In a randomised controlled trial in healthy elderly individuals, it was observed that omega-3 PUFAs potentiated the muscle protein synthesis (MPS) response to simulated feeding (hyperinsulemia-hyperaminoacidemia clamp) following an 8-week supplementation period (1.86 g EPA, 1.5 g DHA/day), independent of increased glu…”
BackgroundInfluentialChavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · cited 1×
“including DAGs, ceramides and long chain acyl-coAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113–118].”
BackgroundPostexercise net protein synthesis in human muscle from orally administered amino acids
Tipton, K. D., Ferrando, A. A., Phillips, S. M., Doyle, D., & Wolfe, R. R. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.4.e628 · Cited by 616
Burdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598 · cited 1×
“However, the conversion of ALA to DHA is very inefficient with <10% conversion in females and <3% in males [31,32].”
BackgroundFat-1 mice convert n-6 to n-3 fatty acids
Kang, J. X., Wang, J., Wu, L., & Kang, Z. B. (2004) · Nature · doi:10.1038/427504a · Cited by 545
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538 · cited 1×
“Yet, it has also been reported that feeding rodents a short term high fat diet increases mitochondrial content and oxidative capacity despite the development of IR [96,97].”
BackgroundExcess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520 · cited 1×
“Yet, it has also been reported that feeding rodents a short term high fat diet increases mitochondrial content and oxidative capacity despite the development of IR [96,97].”
BackgroundFish oil–derived n−3 PUFA therapy increases muscle mass and function in healthy older adults
Smith, G. I., Julliand, S., Reeds, D. N., Sinacore, D. R., Klein, S., & Mittendorfer, B. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105833 · Cited by 507 · cited 3×
“that manipulating the omega-3 polyunsaturated fatty acid (PUFA) content of skeletal muscle may improve muscle function and metabolism [10,11].”
BackgroundSimoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · cited 16×
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
BackgroundInfluentialThiebaud, D., Jacot, E., Defronzo, R. A., Maeder, E., Jequier, E., & Felber, J.-P. (1982) · Diabetes · doi:10.2337/diacare.31.11.957 · Cited by 489
Specialized pro-resolving lipid mediators in the inflammatory response: An update
Bannenberg, G., & Serhan, C. N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.002 · Cited by 464 · cited 1×
“Both EPA and DHA also serve as substrates for resolvins, protectins and maresins which display inflammation resolving properties in both cell culture and animal models of inflammation [150,151].”
BackgroundKyle, U., Genton, L., Hans, D., Karsegard, L., Slosman, D., & Pichard, C. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601198 · Cited by 442 · cited 1×
“5%/year and this loss is accelerated in a diseased state [7].”
BackgroundNuclear factor-kappa B signaling in skeletal muscle atrophy
Li, H., Malhotra, S., & Kumar, A. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0373-8 · Cited by 441
Turner, N., Kowalski, G. M., Leslie, S. J., Risis, S., Yang, C., Lee-Young, R. S., Babb, J. R., Meikle, P. J., Lancaster, G. I., Henstridge, D. C., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2913-1 · Cited by 430 · cited 5×
“The ability to clear blood glucose is diminished in IR/T2D individuals and sustained levels of high blood glucose can lead to negative health outcomes.”
BackgroundInfluentialRole of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 1×
“including DAGs, ceramides and long chain acyl-coAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113–118].”
BackgroundSummers, L. K. M., Fielding, B. A., Bradshaw, H. A., Ilic, V., Beysen, C., Clark, M. L., Moore, N. R., & Frayn, K. N. (2002) · Diabetologia · doi:10.1007/s00125-001-0768-3 · Cited by 414 · cited 16×
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
BackgroundInfluentialRees, D., Miles, E. A., Banerjee, T., Wells, S. J., Roynette, C. E., Wahle, K. W., & Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.331 · Cited by 401
Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703169200 · Cited by 400 · cited 1×
“50%–80% less biologically active than AA derived eicosanoids [149].”
BackgroundBodine, S. C. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.011 · Cited by 389
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · Clinical Science · doi:10.1042/cs20100597 · Cited by 372 · cited 2×
“trend in the effect of omega-3 PUFA on MPS in young and middle aged healthy individuals [62].”
BackgroundInsulin action and insulin resistance in human skeletal muscle
Zierath, J. R., Krook, A., & Wallberg-Henriksson, H. (2000) · Diabetologia · doi:10.1007/s001250051457 · Cited by 367 · cited 17×
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
BackgroundInfluentialTowards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids
Harris, W. S., Mozaffarian, D., Lefevre, M., Toner, C. D., Colombo, J., Cunnane, S. C., Holden, J. M., Klurfeld, D. M., Morris, M. C., & Whelan, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.101329 · Cited by 356
Omega-3 fatty acids and incident type 2 diabetes: A systematic review and meta-analysis
Wu, J. H. Y., Micha, R., Imamura, F., Pan, A., Biggs, M. L., Ajaz, O., Djousse, L., B. Hu, F., & Mozaffarian, D. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001602 · Cited by 340 · cited 1×
“little or no impact of marine derived omega-3 PUFAs on insulin sensitivity or reduction in risk of developing T2D there are a number of human, animal and cell studies which support a potential role of omega-3 PUFAs in the treatment of IR/T2D through alterations in muscle metabolism, and omega-3 PUFAs may protect again…”
BackgroundDocosapentaenoic acid (22:5n-3): A review of its biological effects
Kaur, G., Cameron-Smith, D., Garg, M., & Sinclair, A. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.004 · Cited by 337 · cited 1×
“Omega-3 PUFAs consist of a heterogeneous mixture of fatty acids, of which eicosapentaenoic acid (EPA, 20:5) and docosapentaenoic acid (DHA, 22:6) are currently thought to be the most bioactive of the omega-3 species, however, docosapentaenoic acid (DPA, 22:5), an intermediary of EPA and DHA, may also have beneficial h…”
BackgroundPedersen, O., Bak, J. F., Andersen, P. H., Lund, S., Moller, D. E., Flier, J. S., & Kahn, B. B. (1990) · Diabetes · doi:10.2337/diab.39.7.865 · Cited by 329
Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
Marik, P. E., & Varon, J. (2009) · Clinical Cardiology · doi:10.1002/clc.20604 · Cited by 328 · cited 1×
“are equivocal [40–43].”
Drummond, M. J., Dreyer, H. C., Fry, C. S., Glynn, E. L., & Rasmussen, B. B. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91397.2008 · Cited by 322 · cited 1×
“Instead, this anabolic effect is thought to be partially mediated through an increased phosphorylation of mechanistic target of rapamycin (mTOR) and downstream signalling target P70-S6K1, a key regulatory pathway of protein synthesis and, by extension, muscle mass [64,65].”
BackgroundRyan, A. M., Reynolds, J. V., Healy, L., Byrne, M., Moore, J., Brannelly, N., McHugh, A., McCormack, D., & Flood, P. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819a4789 · Cited by 311 · cited 1×
“However, omega-3 supplementation has been shown in some studies to blunt the loss of skeletal muscle mass [58–60].”
BackgroundEffect of ibuprofen and acetaminophen on postexercise muscle protein synthesis
Trappe, T. A., White, F., Lambert, C. P., Cesar, D., Hellerstein, M., & Evans, W. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00352.2001 · Cited by 293 · cited 2×
“important process in muscle adaptation, failure to effectively resolve inflammation leading to a chronic state of inflammation is associated with IR/T2D and obesity [79,143].”
BackgroundRoden, M., Stingl, H., Chandramouli, V, Schumann, W. C., Hofer, A., Landau, B. R., Nowotny, P., Waldhäusl, W., & Shulman, G. I. (2000) · Diabetes · doi:10.2337/diabetes.49.5.701 · Cited by 288
Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
GLAUBER, H., WALLACE, P., GRIVER, K., & BRECHTEL, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-663 · Cited by 285 · cited 2×
“(1988) [130] Human (T2D) 4 weeks, 18 g fish oil daily Increase in fasting plasma glucose and in response to feeding.”
BackgroundOmega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282
Sarcopenia: Effects on Body Composition and Function
Roubenoff, R. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.11.m1012 · Cited by 282 · cited 1×
“Moreover, as little as a 5% decrease in skeletal muscle mass has been associated with increased morbidity [8].”
BackgroundFish-oil supplementation enhances the effects of strength training in elderly women
Rodacki, C. L., Rodacki, A. L., Pereira, G., Naliwaiko, K., Coelho, I., Pequito, D., & Fernandes, L. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.021915 · Cited by 274
Ellis, B. A., Poynten, A., Lowy, A. J., Furler, S. M., Chisholm, D. J., Kraegen, E. W., & Cooney, G. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e554 · Cited by 273
Mas, E., Croft, K. D., Zahra, P., Barden, A., & Mori, T. A. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.190199 · Cited by 270 · cited 1×
“Both EPA and DHA also serve as substrates for resolvins, protectins and maresins which display inflammation resolving properties in both cell culture and animal models of inflammation [150,151].”
BackgroundRole of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis
Meyer, C., Dostou, J. M., Welle, S. L., & Gerich, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2001 · Cited by 269
POWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267 · cited 1×
“can lead to the activation of PKC isoforms which lead to the phosphorylation of serine residues on insulin receptor substrate-1(IRS) and attenuating PKB activation [119,120].”
BackgroundDimopoulos, N., Watson, M., Sakamoto, K., & Hundal, H. S. (2006) · Biochemical Journal · doi:10.1042/bj20060244 · Cited by 247
Free fatty acids, insulin resistance, and type 2 diabetes mellitus
Boden, G. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99220.x · Cited by 246 · cited 1×
“Lipid induced IR can be observed after only a few hours of increased plasma free fatty acids in vitro and in rodent skeletal muscle within three weeks of a high fat diet [110–112].”
Background'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease
Rees, K., Hartley, L., Flowers, N., Clarke, A., Hooper, L., Thorogood, M., & Stranges, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009825.pub2 · Cited by 242
The importance of lipid type in the diet after burn injury
ALEXANDER, J. W., SAITO, H., OGLE, C. K., & TROCKI, O. (1986) · Annals of Surgery · doi:10.1097/00000658-198607000-00001 · Cited by 236 · cited 1×
“However, omega-3 supplementation has been shown in some studies to blunt the loss of skeletal muscle mass [58–60].”
BackgroundMuscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
Baehr, L. M., Furlow, J. D., & Bodine, S. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212845 · Cited by 234 · cited 1×
“Animal models that lack MURF-1 expression are protected from atrophy [71,72].”
BackgroundThies, F., Nebe-von-Caron, G., Powell, J. R., Yaqoob, P., Newsholme, E. A., & Calder, P. C. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.7.1918 · Cited by 232
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230 · cited 1×
“A study by Rossmeisl and colleagues (2012), observed favourable metabolic changes when omega-3 PUFAs were available as phospholipids compared with TAGs, possibly due to different bio-availabilities [169].”
BackgroundItariu, B. K., Zeyda, M., Hochbrugger, E. E., Neuhofer, A., Prager, G., Schindler, K., Bohdjalian, A., Mascher, D., Vangala, S., Schranz, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037432 · Cited by 227 · cited 1×
“The results of in vivo studies are mixed with some showing a beneficial effect in adipose tissue of severely obese individuals while no effect was seen in moderately overweight individuals [166,167].”
ResultA Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR
Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_22 · Cited by 222 · cited 1×
“The reduction in NF-κB pathway activation is thought to be caused by an up-regulation in PPARγ activity, which is known to interfere with NF-κB activation [154].”
BackgroundFatty acid composition of skeletal muscle reflects dietary fat composition in humans
Andersson, A., Nälsén, C., Tengblad, S., & Vessby, B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1222 · Cited by 221
Ryder, J. W., Yang, J., Galuska, D., Rincón, J., Björnholm, M., Krook, A., Lund, S., Pedersen, O., Wallberg-Henriksson, H., Zierath, J. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.4.647 · Cited by 216
Damsbo, P., Vaag, A., Hother-Nielsen, O., & Beck-Nielsen, H. (1991) · Diabetologia · doi:10.1007/bf00405082 · Cited by 203 · cited 1×
“pool [108,109].”
Holloway, G. P., Bezaire, V., Heigenhauser, G. J. F., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., Bonen, A., & Spriet, L. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.102178 · Cited by 198
Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling
Norris, P. C., & Dennis, E. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200189109 · Cited by 193
Gingras, A., White, P. J., Chouinard, P. Y., Julien, P., Davis, T. A., Dombrowski, L., Couture, Y., Dubreuil, P., Myre, A., Bergeron, K., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.121079 · Cited by 193 · cited 1×
“(2007) [82] Steers 5 weeks infusion 4% menhaden oil Enhanced insulin action alongside an increase in amino acid disposal plus increased mTOR-p70S6K1 in response to hyperinsulinemiceuglycaemic-euaminoacidemic clamp.”
BackgroundElongase reactions as control points in long-chain polyunsaturated fatty acid synthesis
Gregory, M. K., Gibson, R. A., Cook-Johnson, R. J., Cleland, L. G., & James, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029662 · Cited by 192
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid
Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P. A., & Poli, G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1857 · Cited by 188
Popp‐Snijders, C., Schouten, J. A., Heine, R. J., van der Meer, J., & van der Veen, E. A. (1987) · PubMed · Cited by 187
Functional differences in lipid metabolism in resting skeletal muscle of various fiber types
Dyck, D. J., Peters, S. J., Glatz, J., Gorski, J., Keizer, H., Kiens, B., Liu, S., Richter, E. A., Spriet, L. L., van der Vusse, G. J., et al. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.3.e340 · Cited by 186
White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010) · Diabetes · doi:10.2337/db10-0054 · Cited by 185
Herbst, E. A. F., Paglialunga, S., Gerling, C., Whitfield, J., Mukai, K., Chabowski, A., Heigenhauser, G. J. F., Spriet, L. L., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.267336 · Cited by 179 · cited 2×
“Outwith, the context of a high fat diet 12 weeks of omega-3 PUFA supplementation (2 g EPA, 1 g DHA) did not alter mitochondrial abundance in humans, however, did increase ADP sensitivity [102].”
BackgroundTrebble, T. M., Wootton, S. A., Miles, E. A., Mullee, M., Arden, N. K., Ballinger, A. B., Stroud, M. A., Burdge, G. C., & Calder, P. C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.376 · Cited by 179 · cited 1×
“Omega-3 PUFAs have also been shown to increase lymphocyte proliferation as well as altering neutrophil and natural killer cell function [162–165].”
BackgroundHolte, L. L., Peter, S. A., Sinnwell, T. M., & Gawrisch, K. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80422-4 · Cited by 169
Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains
Williams, J. A., Batten, S. E., Harris, M., Rockett, B. D., Shaikh, S. R., Stillwell, W., & Wassall, S. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.016 · Cited by 168
Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis
Djoussé, L., Akinkuolie, A. O., Wu, J. H. Y., Ding, E. L., & Gaziano, J. M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.05.010 · Cited by 168 · cited 1×
“are equivocal [40–43].”
Akinkuolie, A. O., Ngwa, J. S., Meigs, J. B., & Djoussé, L. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.08.013 · Cited by 167 · cited 1×
“(2015) and colleagues observed small reduction in endogenous glucose production while subset analysis of a meta-analysis indicated an increase in hepatic insulin sensitivity [103,124].”
BackgroundCeramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
STRATFORD, S., DEWALD, D. B., & SUMMERS, S. A. (2001) · Biochemical Journal · doi:10.1042/bj3540359 · Cited by 161
Trappe, T. A., Fluckey, J. D., White, F., Lambert, C. P., & Evans, W. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7928 · Cited by 159
Age‐related neuromuscular changes affecting human vastus lateralis
Piasecki, M., Ireland, A., Stashuk, D., Hamilton‐Wright, A., Jones, D. A., & McPhee, J. S. (2016) · The Journal of Physiology · doi:10.1113/jp271087 · Cited by 156
Mostad, I. L., Bjerve, K. S., Bjorgaas, M. R., Lydersen, S., & Grill, V. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.3.540 · Cited by 152 · cited 2×
“For example, Mostad and colleagues (2006) observed that the short term response to intake of omega-3 PUFAs was a decrease in fat oxidation but the opposite effect was observed after nine weeks [92].”
BackgroundIntroduction to Fatty Acids and Lipids
Burdge, G. C., & Calder, P. C. (2015) · World Review of Nutrition and Dietetics · doi:10.1159/000365423 · Cited by 151
Bosma, M., Hesselink, M. K. C., Sparks, L. M., Timmers, S., Ferraz, M. J., Mattijssen, F., van Beurden, D., Schaart, G., de Baets, M. H., Verheyen, F. K., et al. (2012) · Diabetes · doi:10.2337/db11-1402 · Cited by 149
Blaak, E. E., Wagenmakers, A. J. M., Glatz, J. F. C., Wolffenbuttel, B. H. R., Kemerink, G. J., Langenberg, C. J. M., Heidendal, G. A. K., & Saris, W. H. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e146 · Cited by 140 · cited 1×
“between different fuel sources, termed metabolic flexibility, is diminished by obesity and T2D at rest and during exercise [84,85].”
BackgroundLanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135 · cited 5×
“This study observed an increase in mitochondrial abundance and oxidative capacity in response to a high fat diet without any added effect of fish oil [100].”
BackgroundInfluentialWei, D., Li, J., Shen, M., Jia, W., Chen, N., Chen, T., Su, D., Tian, H., Zheng, S., Dai, Y., et al. (2010) · Diabetes · doi:10.2337/db09-0284 · Cited by 132
Shaikh, S. R., Rockett, B. D., & Carraway, K. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.108720 · Cited by 132
Temporal changes in human skeletal muscle and blood lipid composition with fish oil supplementation
McGlory, C., Galloway, S. D. R., Hamilton, D. L., McClintock, C., Breen, L., Dick, J. R., Bell, J. G., & Tipton, K. D. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.03.001 · Cited by 130 · cited 2×
“Several studies have observed a significant enrichment in the muscle total lipid pool and phospholipids by omega-3 PUFAs with an approximate two fold increase during a supplementation period of between four and 12 weeks [21,23,62,63].”
BackgroundSelf-citationFish oils produce anti-inflammatory effects and improve body weight in severe heart failure
Mehra, M. R., Lavie, C. J., Ventura, H. O., & Milani, R. V. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.005 · Cited by 122 · cited 1×
“As a result studies have observed reductions in circulating TNF-α concentrations (which may also provide negative feedback on NF-κB activity), as well as expression of inflammatory cytokines and cell surface adhesion molecules [155–157].”
BackgroundFigueras, M., Olivan, M., Busquets, S., López‐Soriano, F. J., & Argilés, J. M. (2011) · Obesity · doi:10.1038/oby.2010.194 · Cited by 113 · cited 4×
“As well as increasing complex lipid formation, EPA may also improve both basal and insulin stimulated glucose uptake in a manner independent of PKB signalling [93,132].”
BackgroundInfluentialVaughan, R. A., Garcia-Smith, R., Bisoffi, M., Conn, C. A., & Trujillo, K. A. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-142 · Cited by 112 · cited 2×
“Multiple studies have observed an increase in GLUT4 expression [93,94], however, whether this is reflected at the protein level is still unclear with one study showing no change in GLUT4 content with a low dose of omega-3 PUFAs [137].”
Backgroundvan Tienen, F. H. J., Praet, S. F. E., de Feyter, H. M., van den Broek, N. M., Lindsey, P. J., Schoonderwoerd, K. G. C., de Coo, I. F. M., Nicolay, K., Prompers, J. J., Smeets, H. J. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3454 · Cited by 111
Bioactive products formed in humans from fish oils
Skarke, C., Alamuddin, N., Lawson, J. A., Li, X., Ferguson, J. F., Reilly, M. P., & FitzGerald, G. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060392 · Cited by 109
Kamolrat, T., & Gray, S. R. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.041 · Cited by 108 · cited 3×
“C2C12 myotubes treated with EPA showed elevated MPS 25% greater than the control with no effect of DHA despite P70-S6K1 phosphorylation being significantly elevated in both treatments [53].”
BackgroundAKIBA, S., MURATA, T., KITATANI, K., & SATO, T. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.1293 · Cited by 108
Albert, B. B., Derraik, J. G. B., Brennan, C. M., Biggs, J. B., Smith, G. C., Garg, M. L., Cameron-Smith, D., Hofman, P. L., & Cutfield, W. S. (2014) · Scientific Reports · doi:10.1038/srep06697 · Cited by 105 · cited 1×
“A high omega-3 index (erythrocyte concentrations of EPA and DHA) is associated with higher insulin sensitivity and lower fasting insulin levels [126].”
BackgroundMagee, P., Pearson, S., & Allen, J. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-24 · Cited by 105
Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss
Corpeleijn, E., Mensink, M., Kooi, M. E., Roekaerts, P. M. H. J., Saris, W. H. M., & Blaak, E. E. (2008) · Obesity · doi:10.1038/oby.2008.24 · Cited by 104 · cited 1×
“between different fuel sources, termed metabolic flexibility, is diminished by obesity and T2D at rest and during exercise [84,85].”
BackgroundSchmidt, M., Johannesdottir, S. A., Lemeshow, S., Lash, T. L., Ulrichsen, S. P., Bøtker, H. E., & Toft Sørensen, H. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002698 · Cited by 104
Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance
Fasching, P., Ratheiser, K., Waldhäusl, W., Rohac, M., Osterrode, W., Nowotny, P., & Vierhapper, H. (1991) · Diabetes · doi:10.2337/diab.40.5.583 · Cited by 102
Aas, V., Rokling-Andersen, M. H., Kase, E. T., Thoresen, G. H., & Rustan, A. C. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500300-jlr200 · Cited by 101 · cited 7×
“(2005) was an increase in mRNA content of GLUT1, which is involved in the regulation of basal glucose uptake [132,139].”
BackgroundInfluentialDownregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation
Whitehouse, A. S., & Tisdale, M. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5209 · Cited by 100
Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids
Nording, M. L., Yang, J., Georgi, K., Hegedus Karbowski, C., German, J. B., Weiss, R. H., Hogg, R. J., Trygg, J., Hammock, B. D., & Zivkovic, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076575 · Cited by 100 · cited 3×
“Previous studies have observed individual rate uptakes of omega-3 PUFAs into tissues [35], so the same supplementation period and dose may lead to different tissue levels of omega-3 PUFAs between subjects, potentially masking any effect of elevating omega-3 PUFA tissue levels.”
BackgroundInfluentialNiu, K., Hozawa, A., Kuriyama, S., Ohmori-Matsuda, K., Shimazu, T., Nakaya, N., Fujita, K., Tsuji, I., & Nagatomi, R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.223 · Cited by 94 · cited 1×
“Omega-3 PUFAs have also been shown to increase lymphocyte proliferation as well as altering neutrophil and natural killer cell function [162–165].”
BackgroundWalker, C. G., Jebb, S. A., & Calder, P. C. (2013) · Nutrition · doi:10.1016/j.nut.2012.06.003 · Cited by 91 · cited 1×
“There is recent evidence to suggest that supplementing with stearidonic acid (18:3n-3) may improve the efficiency of conversion to DHA, indicating ∆6 desaturase as a rate limiting step [34].”
BackgroundRegulation of muscle protein synthesis in humans
Phillips, B. E., Hill, D. S., & Atherton, P. J. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834d19bc · Cited by 91
Siriwardhana, N., Kalupahana, N. S., Fletcher, S., Xin, W., Claycombe, K. J., Quignard-Boulange, A., Zhao, L., Saxton, A. M., & Moustaid-Moussa, N. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.11.009 · Cited by 89
Jelenik, T., Rossmeisl, M., Kuda, O., Jilkova, Z. M., Medrikova, D., Kus, V., Hensler, M., Janovska, P., Miksik, I., Baranowski, M., et al. (2010) · Diabetes · doi:10.2337/db09-1716 · Cited by 88 · cited 3×
“It may be of interest to assess the importance of AMPK on insulin sensitizing effects of omega-3 PUFAs in skeletal muscle.”
BackgroundYou, J.-S., Park, M.-N., Song, W., & Lee, Y.-S. (2010) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h10-022 · Cited by 88
Capel, F., Acquaviva, C., Pitois, E., Laillet, B., Rigaudière, J.-P., Jouve, C., Pouyet, C., Gladine, C., Comte, B., Vianey Saban, C., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.003 · Cited by 86 · cited 1×
“preventing the deleterious effects of palmitate on PKB phosphorylation and glucose uptake [138].”
BackgroundEffects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans
Delarue, J., Couet, C., Cohen, R., Brechot, J. F., Antoine, J. M., & Lamisse, F. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e353 · Cited by 82
Smink, W., Gerrits, W. J. J., Gloaguen, M., Ruiter, A., & van Baal, J. (2012) · animal · doi:10.1017/s1751731111001479 · Cited by 80
Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M. (2009) · Diabetes · doi:10.2337/db08-1043 · Cited by 73
Lalia, A. Z., Johnson, M. L., Jensen, M. D., Hames, K. C., Port, J. D., & Lanza, I. R. (2015) · Diabetes Care · doi:10.2337/dc14-3101 · Cited by 73
Trenell, M. I., Hollingsworth, K. G., Lim, E. L., & Taylor, R. (2008) · Diabetes Care · doi:10.2337/dc08-0303 · Cited by 71 · cited 1×
“A number of studies have also reported normal mitochondrial function in insulin resistant populations [98,99].”
BackgroundMetabolic switching of human myotubes is improved by n-3 fatty acids
Hessvik, N. P., Bakke, S. S., Fredriksson, K., Boekschoten, M. V., Fj⊘rkenstad, A., Koster, G., Hesselink, M. K., Kersten, S., Kase, E. T., Rustan, A. C., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003319 · Cited by 71 · cited 3×
“(2005) do not detect any differences in basal and insulin stimulated PKB phosphorylation [88,132].”
BackgroundComparative actions of omega-3 fatty acids on in-vitro lipid droplet formation
Barber, E., Sinclair, A. J., & Cameron‐Smith, D. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.07.006 · Cited by 68
Altenburg, J. D., & Siddiqui, R. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0385 · Cited by 67 · cited 1×
“EPA are incorporated into insoluble membrane fractions and lead to the ‘declustering’ of lipid rafts due to the poor affinity between omega-3 PUFAs and cholesterol, leading to the expulsion of cholesterol from the lipid rafts [171,173].”
BackgroundJohnson, M. L., Lalia, A. Z., Dasari, S., Pallauf, M., Fitch, M., Hellerstein, M. K., & Lanza, I. R. (2015) · Aging Cell · doi:10.1111/acel.12352 · Cited by 66
Dietary Fish Oil Increases Acetylcholine- and Eicosanoid-Induced Contractility of Isolated Rat Ileum
Patten, G. S., Abeywardena, M. Y., McMurchie, E. J., & Jahangiri, A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.9.2506 · Cited by 66
Omega-3: A link between global climate change and human health
Kang, J. X. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.02.003 · Cited by 66
Magee, P., Pearson, S., Whittingham-Dowd, J., & Allen, J. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.005 · Cited by 65 · cited 2×
“Briefly EPA and, to a lesser extent, DHA are natural ligands for Peroxisome proliferator-activated Receptor γ (PPARγ) and following activation of PPARγ NF-κB activity is suppressed reducing the release of pro-inflammatory cytokines [68].”
BackgroundThe effect of n-3 fatty acids on neutrophil chemiluminescence
Varming, K., Schmidt, E. B., Svaneborg, N., Møller, J. M., Lervang, H.-H., Grunnet, N., Jersild, C., & Dyerberg, J. (1995) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519509075377 · Cited by 64
Kanayasu‐Toyoda, T., Morita, I., & Murota, S. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90045-9 · Cited by 64
Essential fatty acids in membrane: physical properties and function
Stubbs, C. D., & Smith, A. D. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180779 · Cited by 63
Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men
Reinders, I., Virtanen, J. K., Brouwer, I. A., & Tuomainen, T.-P. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.195 · Cited by 59
Thifault, É., Cormier, H., Bouchard‐Mercier, A., Rudkowska, I., Paradis, A.-M., Garneau, V., Ouellette, C., Lemieux, S., Couture, P., & Vohl, M. (2013) · Lifestyle Genomics · doi:10.1159/000350744 · Cited by 54
Pillon, N. J., Arane, K., Bilan, P. J., Chiu, T. T., & Klip, A. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-30 · Cited by 53 · cited 1×
“For instance, conditioned media from palmitate treated macrophages induces insulin resistance in skeletal muscle cells [158].”
BackgroundDangardt, F., Chen, Y., Gronowitz, E., Dahlgren, J., Friberg, P., & Strandvik, B. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/395757 · Cited by 52
Delarue, J., Li, C.-H., Cohen, R., Corporeau, C., & Simon, B. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051631 · Cited by 48
Kamolrat, T., Gray, S. R., & Thivierge, M. C. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0368-7 · Cited by 47
A successful diabetes prevention study in Eskimos: The Alaska Siberia project
Ebbesson, S. O. E., Ebbesson, L. O. E., Swenson, M., Kennish, J. M., & Robbins, D. C. (2005) · International Journal of Circumpolar Health · doi:10.3402/ijch.v64i4.18017 · Cited by 46 · cited 1×
“traditional diet of Inuit populations which is high in omega-3 PUFAs and low in omega-6 fatty acids is associated with a lowered risk of cardiovascular disease and improved insulin sensitivity despite being a diet very high in fat [16,17].”
BackgroundMatravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46 · cited 8×
“ALA can be metabolized to eicosapentaenoic acid (EPA 20:5n-3) and docosahexaenoic acid (DHA 22:6n-3) by ∆6 desaturase and ∆5 desaturase respectively, while LA is converted to arachidonic acid (AA 22:4n-6).”
BackgroundInfluentialLe Foll, C., Corporeau, C., Le Guen, V., Gouygou, J.-P., Bergé, J.-P., & Delarue, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2006 · Cited by 45
Romanatto, T., Fiamoncini, J., Wang, B., Curi, R., & Kang, J. X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.017 · Cited by 42
Huang, F., Wei, H., Luo, H., Jiang, S., & Peng, J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510003703 · Cited by 40
Zhao, X., Wang, Z., Zhang, J., Hua, J., He, W., & Zhu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053561 · Cited by 39 · cited 1×
“Skeletal muscle (depending on adiposity levels) accounts for approximately 40% of total body mass and is highly adaptable to environmental changes such as diet and physical activity levels [3,4].”
BackgroundWang, Y., Lin, Q.-W., Zheng, P.-P., Zhang, J.-S., & Huang, F.-R. (2013) · BioMed Research International · doi:10.1155/2013/318981 · Cited by 38 · cited 2×
“Contrary to other studies which observed no effect of DHA on protein breakdown, Wang et al. (2013) observed that DHA attenuated protein degradation through the same mechanisms as EPA but with greater efficiency [74].”
BackgroundResultBradley, N. S., Heigenhauser, G. J. F., Roy, B. D., Staples, E. M., Inglis, J. G., LeBlanc, P. J., & Peters, S. J. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00636.2007 · Cited by 37
Kratz, M., Kuzma, J. N., Hagman, D. K., van Yserloo, B., Matthys, C. C., Callahan, H. S., & Weigle, D. S. (2013) · The Journal of Nutrition · doi:10.3945/jn.113.174383 · Cited by 35
A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance
Smith, B. K., Holloway, G. P., Reza-Lopez, S., Jeram, S. M., Kang, J. X., & Ma, D. W. L. (2010) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h10-066 · Cited by 35 · cited 1×
“Reductions in the n-6/n-3 ratio are associated with an improvement in whole body glucose tolerance, as well as preventing the age related decline in glucose tolerance [45,46].”
BackgroundStephens, F. B., Mendis, B., Shannon, C. E., Cooper, S., Ortori, C. A., Barrett, D. A., Mansell, P., & Tsintzas, K. (2014) · Clinical Science · doi:10.1042/cs20140031 · Cited by 35 · cited 2×
“Yet, a recent study has observed that addition of omega-3 PUFAs to an intravenous lipid infusion attenuated the decline in insulin stimulated glucose action in muscle as well as an increased glucose disposal compared to an omega-6 infusion, these effects were independent of changes in acyl carnitine levels; a marker o…”
BackgroundResultFish oil supplementation augments post-exercise immune function in young males
Gray, P., Gabriel, B., Thies, F., & Gray, S. R. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.002 · Cited by 34
Delarue, J., Labarthe, F., & Cohen, R. (2003) · British Journal of Nutrition · doi:10.1079/bjn2003964 · Cited by 34
Stretton, C., Evans, A., & Hundal, H. S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2010 · Cited by 33 · cited 1×
“can lead to the activation of PKC isoforms which lead to the phosphorylation of serine residues on insulin receptor substrate-1(IRS) and attenuating PKB activation [119,120].”
BackgroundKubota, H., Matsumoto, H., Higashida, M., Murakami, H., Nakashima, H., Oka, Y., Okumura, H., Yamamura, M., Nakamura, M., & Hirai, T. (2013) · PubMed · Cited by 32
You, J.-S., Park, M.-N., & Lee, Y.-S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.07.007 · Cited by 24
Jeng, J.-Y., Lee, W.-H., Tsai, Y.-H., Chen, C.-Y., Chao, S.-Y., & Hsieh, R.-H. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902021h · Cited by 24 · cited 1×
“There is some evidence that omega-3 PUFAs may stimulate mitochondrial biogenesis through the increased mRNA expression of transcription factors such as PCG1-alpha, TFAM and NRF1 [100,101].”
Background
Cited by
Omega-3 Polyunsaturated Fatty Acids: Benefits and Endpoints in Sport
Gammone, M. A., Riccioni, G., Parrinello, G., & D’Orazio, N. (2018) · Nutrients · doi:10.3390/nu11010046 · Cited by 326
“In addiction, a reduction in circulating tumor necrosis factor α (TNF-α) concentrations, as well as in the expression of inflammatory cytokines and cell surface adhesion molecules has been observed [33].”
BackgroundChanges in Plasma Free Fatty Acids Associated with Type-2 Diabetes
I. S. Sobczak, A., A. Blindauer, C., & J. Stewart, A. (2019) · Nutrients · doi:10.3390/nu11092022 · Cited by 304
“A large body of work has been dedicated to long-chain n-3 PUFAs [69,71,128,134,265,266], whilst less information is available for MUFAs [145,267] and n-6 PUFAs [208].”
Backgroundω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
D’Angelo, S., Motti, M. L., & Meccariello, R. (2020) · Nutrients · doi:10.3390/nu12092751 · Cited by 250
“In addition to ALA, ω-3 PUFAs can be defined as a heterogeneous mix of FAs, among which eicosapentaenoic acid (EPA, 20:5n-3) and docosapentaenoic acid (DHA, 22:6n-3) are presently thought to be the most bioactive of theω-3 species; however, docosapentaenoic acid (DPA, 22:5), an intermediate of EPA and DHA, may also ha…”
BackgroundInfluentialDietary Supplements for Health, Adaptation, and Recovery in Athletes
Rawson, E. S., Miles, M. P., & Larson-Meyer, D. E. (2018) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2017-0340 · Cited by 201
“Omega 3-fatty acids: Dose most commonly studied is about 2 g/day (Jeromson et al., 2015; Mickleborough, 2013).”
BackgroundAthletes’ nutritional demands: a narrative review of nutritional requirements
Amawi, A., AlKasasbeh, W., Jaradat, M., Almasri, A., Alobaidi, S., Hammad, A. A., Bishtawi, T., Fataftah, B., Turk, N., Saoud, H. A., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1331854 · Cited by 154
“It is recommended to take omega-3 after or with a high-fat meal for optimal absorption (79).”
Background
Metadata
- Authors
- Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D.
- Affiliations
- University of Stirling (GB)
- Corresponding author
- Hamilton, D.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2015-11-19
- Volume
- 13
- Issue
- 11
- Pages
- 6977-7004
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC4663562
- OpenAlex
- W2174795486
- Semantic Scholar
- 55dad5cb9aa9bf449acfeaa34ba99c6212c5c4fb
- Cited by
- 203
- References
- 180
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 15 · 2022: 17 · 2021: 20 · 2020: 30 · 2019: 22 · 2018: 21 · 2017: 11 · 2016: 6
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Own your potential (DEAKIN) (submittedVersion)
- Stirling Online Research Repository (University of Stirling) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Keywords
- omega-3 fatty acids, skeletal muscle, muscle metabolism, exercise training response, n-6/n-3 ratio, inflammation, aging, physical function, muscle plasticity
- MeSH terms
- Aging, Animals, Humans, Inflammation, Fatty Acids, Omega-3, Muscle, Skeletal, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
